GENE ONLINE|News &
Opinion
Blog

AAV Capsids
Asia-Pacific AAV Gene Therapy
Astellas Taps Dyno in $1.6+ Billion Deal to Develop AAV Gene Therapies
2021-12-02
Licensing Gene Therapy
Voyager Therapeutics’ Novel AAV Capsid Tech for Gene Therapy Attracts Pfizer’s Investment
2021-10-07
Funding Viral Vector
North Carolina-Based Gene Therapy Startup Bags $81.5 Million in Series B Funding
2021-03-17
M&A Gene Therapy
Is Bayer’s Entry to the Gene Therapy Market Worth it’s Investment?
2020-10-27
Technology AAV
Harvard Spinout Bags $1.8 Billion Worth Gene Therapy Deal with Roche
2020-10-15
LATEST
Pfizer’s RSV Vaccine Gets FDA Approval for Use in Older Adults
2023-05-31
Brazil’s Evolving ESG Landscape from the Amazon to Atlantic Forest
2023-05-31
Should People Looking to Lose Weight Skip Sugar Substitutes?
2023-05-30
Advancing Next-Generation Cancer Metabolic Therapy by Targeting Critical Amino Acid Metabolic Pathways: An Interview with Brian A. Van Tine, MD, PhD
2023-05-26
Rona Therapeutics, Keymed Biosciences Team Up To Develop siRNA Drugs For Kidney Disease
2023-05-25
CDC Calls an End to J&J’s COVID-19 Vaccine in the U.S.
2023-05-25
A Close Look at the Evolution of ESG in Biopharma
2023-05-22
READ MORE
EVENT
2023-06-02
2023 ASCO annual meeting
Chicago, USA
2023-06-05
Redefining Early Stage Investments (RESI) 2023 conference series – RESI Boston
Boston, USA
2023-07-26
BIO Asia-Taiwan 2023
Taipei, Taiwan
2023-09-06
2023 Bio Asia Pacific
Bangkok, Thailand
2023-11-16
3rd INTERNATIONAL CONFERENCE ON NUTRITION AND HEALTHCARE
Dubai, UAE
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2023 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top